Jennifer Kamocsay - 01 Mar 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Legal Officer
Signature
/s/ Jennifer Kamocsay, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
01 Mar 2025
Net transactions value
-$12,135
Form type
4
Filing time
04 Mar 2025, 17:16:21 UTC
Previous filing
21 Nov 2024
Next filing
10 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Tax liability $6,277 -3,851 -2.1% $1.63 182,866 01 Mar 2025 Direct F1
transaction AKYA Common Stock Tax liability $5,858 -3,594 -2% $1.63 179,272 01 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to cover taxes on a restricted stock unit award previously granted March 20, 2023, which vests in four (4) equal annual installments beginning on March 1, 2024, and annually thereafter until fully vested.
F2 Represents shares withheld to cover taxes on a restricted stock unit award previously granted February 22, 2024, which vests in four (4) equal annual installments beginning on March 1, 2025, and annually thereafter until fully vested.